Logo image of FORA

FORIAN INC (FORA) Stock Fundamental Analysis

NASDAQ:FORA - Nasdaq - US34630N1063 - Common Stock - Currency: USD

1.87  -0.02 (-1.06%)

Fundamental Rating

4

Taking everything into account, FORA scores 4 out of 10 in our fundamental rating. FORA was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for FORA as it has an excellent financial health rating, but there are worries on the profitability. FORA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year FORA has reported negative net income.
In the past year FORA had a positive cash flow from operations.
In the past 5 years FORA reported 4 times negative net income.
In multiple years FORA reported negative operating cash flow during the last 5 years.
FORA Yearly Net Income VS EBIT VS OCF VS FCFFORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

FORA has a better Return On Assets (-7.58%) than 68.57% of its industry peers.
Looking at the Return On Equity, with a value of -12.26%, FORA is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -7.58%
ROE -12.26%
ROIC N/A
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
FORA Yearly ROA, ROE, ROICFORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

FORA has a Gross Margin (60.76%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FORA has grown nicely.
The Profit Margin and Operating Margin are not available for FORA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
FORA Yearly Profit, Operating, Gross MarginsFORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

7

2. Health

2.1 Basic Checks

FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FORA has more shares outstanding
The number of shares outstanding for FORA has been reduced compared to 5 years ago.
FORA has a better debt/assets ratio than last year.
FORA Yearly Shares OutstandingFORA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FORA Yearly Total Debt VS Total AssetsFORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.21, we must say that FORA is in the distress zone and has some risk of bankruptcy.
FORA has a Altman-Z score (1.21) which is comparable to the rest of the industry.
There is no outstanding debt for FORA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.3
Altman-Z 1.21
ROIC/WACCN/A
WACC9.87%
FORA Yearly LT Debt VS Equity VS FCFFORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.50 indicates that FORA has no problem at all paying its short term obligations.
With a Current ratio value of 2.50, FORA perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Quick Ratio of 2.50 indicates that FORA has no problem at all paying its short term obligations.
FORA's Quick ratio of 2.50 is in line compared to the rest of the industry. FORA outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
FORA Yearly Current Assets VS Current LiabilitesFORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for FORA have decreased strongly by -220.00% in the last year.
Looking at the last year, FORA shows a quite strong growth in Revenue. The Revenue has grown by 9.01% in the last year.
Measured over the past years, FORA shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%44.67%

3.2 Future

Based on estimates for the next years, FORA will show a very strong growth in Earnings Per Share. The EPS will grow by 66.28% on average per year.
Based on estimates for the next years, FORA will show a very strong growth in Revenue. The Revenue will grow by 27.74% on average per year.
EPS Next Y142.5%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.61%
Revenue Next 2Y27.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FORA Yearly Revenue VS EstimatesFORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
FORA Yearly EPS VS EstimatesFORA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

FORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
FORA is valuated rather expensively with a Price/Forward Earnings ratio of 20.37.
FORA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FORA is cheaper than 77.14% of the companies in the same industry.
FORA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.94.
Industry RankSector Rank
PE N/A
Fwd PE 20.37
FORA Price Earnings VS Forward Price EarningsFORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

FORA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FORA is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.79
EV/EBITDA N/A
FORA Per share dataFORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

FORA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FORA's earnings are expected to grow with 66.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FORA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORIAN INC

NASDAQ:FORA (8/21/2025, 3:01:46 PM)

1.87

-0.02 (-1.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners13.33%
Inst Owner Change-0.4%
Ins Owners51.93%
Ins Owner Change7.63%
Market Cap58.18M
Analysts82.86
Price Target5.1 (172.73%)
Short Float %0.63%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)50.98%
Min EPS beat(2)-30.72%
Max EPS beat(2)132.68%
EPS beat(4)2
Avg EPS beat(4)-30.72%
Min EPS beat(4)-292.16%
Max EPS beat(4)132.68%
EPS beat(8)5
Avg EPS beat(8)72.22%
EPS beat(12)9
Avg EPS beat(12)55.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.55%
Min Revenue beat(2)6.15%
Max Revenue beat(2)28.95%
Revenue beat(4)2
Avg Revenue beat(4)4.89%
Min Revenue beat(4)-10.98%
Max Revenue beat(4)28.95%
Revenue beat(8)3
Avg Revenue beat(8)0.29%
Revenue beat(12)5
Avg Revenue beat(12)-3.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)133.33%
EPS NY rev (1m)0%
EPS NY rev (3m)141.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)30.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)29.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.37
P/S 2.61
P/FCF 19.79
P/OCF 19.79
P/B 1.94
P/tB 2.01
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.09
Fwd EY4.91%
FCF(TTM)0.09
FCFY5.05%
OCF(TTM)0.09
OCFY5.05%
SpS0.72
BVpS0.97
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.58%
ROE -12.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.76%
FCFM 13.16%
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.3
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z 1.21
F-Score4
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)53.55%
Cap/Depr(5y)146.6%
Cap/Sales(3y)2.15%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y142.5%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.01%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%44.67%
Revenue Next Year46.61%
Revenue Next 2Y27.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-93.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.35%
OCF growth 3YN/A
OCF growth 5YN/A